Cite
HARVARD Citation
Schütz, N. et al. (2020). Real world outcomes with Bortezomib Thalidomide dexamethasone and Cyclophosphamide Bortezomib dexamethasone induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple. Hematological oncology. 38 (3), pp. 363-371. [Online].